Advertisement
Advertisement

RANI

RANI logo

Rani Therapeutics Holdings, Inc. Class A Common Stock

0.97
USD
Sponsored
+0.03
+3.71%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

0.97

0.00
+0.36%

Rani Therapeutics Holdings, Inc. Class A Common Stock Profile

About

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Info & Links

CEO

Talat Imran

Headquarters

2051 RINGWOOD AVENUE
SAN JOSE, CA 95131, UNITED STATES

Sector

Medical

Auditor

CBIZ CPAS P.C.

Share holders

131

Employees

71

Rani Therapeutics Holdings, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization2

96.72M

Enterprise Value

78.10M

Enterprise Value/EBITDA(ttm)

-2.08

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.28

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-1232.15%

Return on Equity(ttm)

-774.04%

Return on Invested Capital(ttm)

-2020.58%

Return on Assets(ttm)

-106.02%

Income Statement

Revenue(ttm)

1.63M

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

1.63M

EBITDA(ttm)3

-37.48M

Net Income Available to Common(ttm)

-29.67M

Diluted EPS(ttm)

-0.59

Share Statistics

Beta (5Y Monthly)

0.64

52-Week Change

24.42%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

123.69M

Dividend Yield

0.00%

Float4

90.90M

% Held by Insiders

26.51%

% Held by Institutions

30.19%

Balance Sheet

Total Cash(mrq)

49.71M

Total Cash Per Share(mrq)

0.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.21%

Quick Ratio(mrq)

4.21%

Book Value Per Share(mrq)

0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.28

Free Cash Flow(ytd)

-18.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement